To investigate the effect of chronic experimental diabetes on skin allografts in rats as a simple model that could clarify some basic aspects and mechanisms involved in transplant rejection in diabetes compared to normal animals.
Introduction
Diabetes mellitus (DM) is an important cause of mortality and morbidity worldwide, through both direct clinical complications and the high risk for cardiovascular and kidney diseases.
Systematic analysis 1 showed that hyperglycaemia and diabetes are a rising global hazard, considering that the number of adults with diabetes more than doubled over nearly three decades.
The proportion of patients with diabetes mellitus that progresses to End Stage Renal Disease is increasing. The increased prevalence of diabetes mellitus is estimated to account for 28% incidence of renal replacement therapy in general 2 and diabetes mellitus is the most common cause of end-stage renal disease in the United States, accounting for up to 46% of patients on renal replacement therapy each year 3 .
Following kidney transplantation, the prevalence of rejection in patients with diabetes mellitus is slightly but not signifi cantly higher than in non-diabetic subjects 4 . It has been shown that the fi ve year graft survival was 74% for nondiabetics, 72% for those with type 1 diabetes and 47% for those with type 2 diabetes.
Ten year graft survival was 65% for non-diabetics and 59% for those with type 1 diabetes. Forty-four percent of the non-diabetic recipients developed acute rejection episodes, as did 50% of recipients with type 1 and 57.1% of recipients with type 2 diabetes
Clinical and experimental data concerning acute kidney transplantation rejection in diabetes mellitus is scarce 4 .
We investigated the effect of chronic experimental diabetes on skin allografts in rats as a simple model that could clarify some basic aspects and mechanisms involved in acute transplant rejection in diabetes.
Methods
Wistar rats of both sex, were kept at the animal facility in standardized conditions of temperature and light/dark cycles for ten days for adaptation prior to any procedure. Animals from outbred stocks were used as donors and recipients, more similar to the clinical conditions. The experimental protocol was approved by the Institutional Ethical Committee on Animal Experiments. Animals were assigned by chance to two groups, in the experimental group n=10 (G1) diabetic animals received skin graft from nondiabetic rats and in the control group n=14 (G2) nondiabetic rats received skin graft from nondiabetic rats.
Tail-to-dorsum skin transplants were performed. Briefl y, animals were anesthetized with eter, the dorsum was washed and a wound was created to be fi lled with the transplanted tail skin.
The graft was gently placed on the wound surface. The tail grafts, a skin fragment of approximately 6.25 cm 2 was used. Grafting was fi xed with nylon 3.0 stitches. On day fourteen, animals were sacrifi ced, graft removed with a 5 mm of animal skin edge and collected in 10% formalin.
Histology was performed on tissue sections (4 µm) after paraffi n-embedding and staining with haematoxylin-eosin (HE) using standard protocols, at least two sections and four fragments were analyzed for it sample. Grafts were scored blindly by an ex- Statistical analysis was performed with ANOVA (parametric variables) and x 2 (categorical variables), data are reported as mean ± SD. P values less than 0.05 was considered statistically signifi cant.]
Results
Average weight for the diabetic (G1) and control (G2) groups was respectively 259.3g (71) Diabetic group showed mainly cellular and/or humoral acute rejection with few animals in the initial phase of chronicity.
Immunohistochemistry of the infi ltrate showed: 70% of T lymphocytes, 30% of macrophages, and negative for B lymphocytes.
Control group was characterized by low intensity acute cellular rejection with well established chronicity (p = 0.13).
Discussion
Medawar et al. Law. This experimental model is still used as the gold standard in studies of transplant immunology including reconstructive sur-gery. After over six decades, however, the precise mechanism of skin allograft rejection remains still ill-defined 8 .
The major complication with this technique is the partial or complete ischemic necrosis of the flap, a process that has been attributed to an inadequate blood supply as a consequence of insufficient vascularization, vasospasm, impaired venous return and thrombosis 9 that is enhanced in diabetes.
Our most significant finding was related to the vascular inflammatory infiltrate that was prominent in the diabetic group compared to controls characterizing more intense acute rejection, as the ischemic necrosis of the epidermis typical of the inflammatory process. Futhermore, diabetic animals didn't show any signs of chronification. Control animals on the other hand presented mild acute cellular rejection and evident chronification.
Both groups exhibited lymphocytic infiltration of the hair follicles, neovascularization, ulceration and edema. We recognize that the use of outbred animals is a weakness in our data analysis but we must take in consideration that in the clinical scenario of human transplantation in most of the cases there is no perfect matching between donor and recipient. Alloxan is widely used to induce experimental diabetes and the mechanism of its action has been intensively investigated and now is well known. The cytotoxicity to the beta cell is mediated by reactive oxygen species and does not interfere with the animal immune system differently from strepto- 
Conclusion
Skin transplant acute rejection from chronic alloxan diabetic rats to normal donors was significantly more intense than the skin transplant acute rejection between normal animals.
